CGON financials
CG Oncology (CGON) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CGON income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $4.04M | -$607.00K | -$190.77M | -$161.00M | -2.08 |
| 2024 | $1.14M | -$80.96M | -$114.67M | -$88.04M | -1.41 |
| 2023 | $204.00K | -$45.55M | -$55.45M | -$48.61M | -1.02 |
| 2022 | $191.00K | $176.00K | -$35.25M | -$35.44M | -0.66 |
| 2021 | $10.36M | $10.35M | -$12.61M | -$12.84M | -0.28 |
- CGON revenue was $4.04M in fiscal 2025, net income -$161.00M.
Updated 2026-11-07 11:56 UTC